We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,725 results
  1. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study

    Aims/hypothesis

    Impaired awareness of hypoglycaemia (IAH) in type 1 diabetes may develop through a process referred to as habituation. Consistent with...

    Catriona M. Farrell, Alison D. McNeilly, ... Rory J. McCrimmon in Diabetologia
    Article Open access 27 November 2023
  2. The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode

    Background

    Hypoglycaemia has been shown to induce a systemic pro-inflammatory response, which may be driven, in part, by the adrenaline response....

    Clementine E. M. Verhulst, Julia I. P. van Heck, ... Bastiaan E. de Galan in Cardiovascular Diabetology
    Article Open access 08 February 2024
  3. Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies

    Hypoglycaemia, which occurs when blood levels of glucose fall below what is considered a normal range, is a well-known complication of insulin...

    Jasleen Kaur, Elizabeth R. Seaquist in Nature Reviews Endocrinology
    Article 31 October 2022
  4. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

    Aims/hypothesis

    This study compared the frequency of hypoglycaemia, time to hypoglycaemia and recovery from hypoglycaemia after double or triple doses...

    Thomas R. Pieber, Kristine N. Arfelt, ... Hanne Haahr in Diabetologia
    Article Open access 13 June 2023
  5. Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial

    Aims/hypothesis

    Consumption of excess carbohydrates to manage hypoglycaemia can lead to rebound hyperglycaemia and promote weight gain. The objective...

    Christian Laugesen, Ajenthen G. Ranjan, ... Kirsten Nørgaard in Diabetologia
    Article Open access 11 April 2023
  6. Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review

    People with type 1 diabetes experience challenges in managing blood glucose around exercise. Previous studies have examined glycaemic responses to...

    Simon Helleputte, Jane E. Yardley, ... Patrick Calders in Diabetologia
    Article 04 April 2023
  7. Consequences of recurrent hypoglycaemia on brain function in diabetes

    The discovery of insulin and its subsequent mass manufacture transformed the lives of people with type 1 and 2 diabetes. Insulin, however, was a drug...

    Rory J. McCrimmon in Diabetologia
    Article Open access 18 March 2021
  8. Minimising hypoglycaemia in the real world: the challenge of insulin

    Insulin therapy has been a life saver for people with type 1 diabetes and has been an essential tool in the therapy of people with...

    Chantal Mathieu in Diabetologia
    Article 16 January 2021
  9. Non-invasive and minimally invasive glucose monitoring devices: a systematic review and meta-analysis on diagnostic accuracy of hypoglycaemia detection

    Background

    The use of minimally and non-invasive monitoring systems (including continuous glucose monitoring) has increased rapidly over recent years....

    Nicole Lindner, Aya Kuwabara, Tim Holt in Systematic Reviews
    Article Open access 10 May 2021
  10. No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study

    Aims/hypothesis

    It is generally recommended to reduce basal insulin doses after exercise to reduce the risk of post-exercise nocturnal hypoglycaemia....

    Linda C. A. Drenthen, Mandala Ajie, ... Bastiaan E. de Galan in Diabetologia
    Article Open access 07 March 2023
  11. Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study

    Introduction

    Hypoglycaemia is a common side effect of insulin therapy; low or high glycated haemoglobin (HbA 1c ) levels, history of hypoglycaemia or...

    Harold W. de Valk, Michael Feher, ... Gian Paolo Fadini in Diabetes Therapy
    Article Open access 14 July 2020
  12. Incretins beyond type 2 diabetes

    Incretin-based therapies, in particular glucagon-like peptide-1 (GLP-1) receptor agonists, have been evaluated in other forms of diabetes, but...

    Chantal Mathieu, Iraj Ahmadzai in Diabetologia
    Article 08 August 2023
  13. Assessment of selected muscle damage markers and zonulin concentration after maximum-intensity exercise in men with type 1 diabetes treated with a personal insulin pump

    Aim

    Exercise-induced muscle damage depends on exercise intensity and duration and on individual susceptibility. Mechanical and metabolic stress may...

    Bartłomiej Matejko, Łukasz Tota, ... Tomasz Klupa in Acta Diabetologica
    Article Open access 22 July 2023
  14. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus

    Although continuous glucose monitoring (CGM) devices are now considered the standard of care for people with type 1 diabetes mellitus, the uptake...

    Ramzi A. Ajjan, Tadej Battelino, ... Samuel Seidu in Nature Reviews Endocrinology
    Article 08 April 2024
  15. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies

    Aims/hypothesis

    For individuals living with type 1 diabetes, closed-loop insulin delivery improves glycaemic control. Nonetheless, maintenance of...

    Sémah Tagougui, Nadine Taleb, ... Rémi Rabasa-Lhoret in Diabetologia
    Article 01 August 2020
  16. Tirzepatide: A Review in Type 2 Diabetes

    Tirzepatide (Mounjaro ® ), a first-in-class dual incretin agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1...

    Nicole L. France, Yahiya Y. Syed in Drugs
    Article 23 February 2024
  17. Ectopic insulinoma: a systematic review

    Knowledge of ectopic insulinomas comes from single cases. We performed a systematic review through PubMed, Web of Science, Embase, eLibrary and...

    Fernando Guerrero-Pérez, Nuria Vilarrasa, ... Carles Villabona in Reviews in Endocrine and Metabolic Disorders
    Article 12 July 2023
  18. Exercise in adults with type 1 diabetes mellitus

    Regular physical activity improves cardiometabolic and musculoskeletal health, helps with weight management, improves cognitive and psychosocial...

    Michael C. Riddell, Anne L. Peters in Nature Reviews Endocrinology
    Article 31 October 2022
  19. A perspective on treating type 1 diabetes mellitus before insulin is needed

    Type 1 diabetes mellitus (T1DM) is a progressive autoimmune disease that starts long before a clinical diagnosis is made. The American Diabetes...

    Danijela Tatovic, Parth Narendran, Colin M. Dayan in Nature Reviews Endocrinology
    Article 13 March 2023
  20. A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study

    Aims/hypothesis

    Approximately 25% of people with type 1 diabetes have suppressed counterregulatory hormonal and symptomatic responses to...

    Catriona M. Farrell, Alison D. McNeilly, ... Rory J. McCrimmon in Diabetologia
    Article Open access 15 January 2020
Did you find what you were looking for? Share feedback.